MONSANTO
Monsanto Belgium has this year again been recognised in the top ten best places to work in Belgium. Monsanto was awarded 6 th place in the category ‘companies with more than 500 employees’ at the ‘Best Workplaces 2015’ award ceremony held on Tuesday 10 th March, in Brussels, Belgium. The awards are part of an annual ranking of businesses by the Great Place to Work Institute in partnership with the Vlerick Business School.
Monsanto credits this recognition to human resources (HR) policies that strongly focus on the development and progress of employees. These policies have helped to foster an attractive work environment, and Monsanto Belgium is proud that on average, employees at the Antwerp site have been with the company for 20 years.
The annual ranking of ‘Best Workplaces’ is determined thorough an independent analysis of a company’s culture and HR policies, as well as employee interviews.
CEO of their own career
Building on the three company values – to work together, to inspire and to guide – Monsanto has built a strong HR policy that supports its employees in designing their own successful careers within the company. Each employee outlines his or her goals and future aspirations within the organisation and with the support of management, works to build his or her own career plan.
“At Monsanto, our employees are the CEO of their own career. Because our employees are responsible for their development in the organisation, we motivate them to think seriously about their future and to translate this into a concrete, individual development plan, ” explains Luc Verstraete, HR Lead for Monsanto in Belgium.
“We are really proud of our place in the top 10, and for our HR vision to be rewarded with the 6 th place ranking,” he continued. “We see this as confirmation and motivation to continue building our vision. We aim to continuously improve our HR systems, involve our employees and managers in HR policy, and communicate even more transparently with our employees. ”
Diverse and sustainable recruitment
Monsanto Belgium is continuously looking for talented employees across a diverse range of backgrounds. Each year, the company offers approximately 40 traineeships across all departments for young workers, and participates in the ‘Summer Challenge’- an annual summer work experience placement for students in first year bachelor Industrial or Chemical Sciences. Monsanto Belgium also actively participates in programmes for job seekers from less advantaged backgrounds. Monsanto Belgium was one of the founding partners of the ‘SIRA initiative ’—an initiative run by the vzw Scheikundige Industrie Regio Antwerpen and social partners—that seeks to place young job seekers without qualifications in placements in the chemical sector with a view to possible recruitment.
Monsanto Belgium actively encourages employee involvement in local community and charity events such as the ‘Antwerp 10 miles ’, the ‘Drakenbootfestival ’, ‘Kom op tegen Kanker ’ and ‘Bloed geven doet leven ’.
About Monsanto
Monsanto is a sustainable agriculture company with more than 22,000 employees worldwide. We produce seeds for fruits, vegetables and key crops – such as corn, soybeans, and cotton – that help farmers have better harvests while using water and other important resources more efficiently. We work collaboratively to find sustainable solutions for soil health, help farmers use data to improve farming practices and conserve natural resources, and provide crop protection products to minimize damage from pests and disease.
In Belgium, Monsanto has a chemical production site in Antwerp with over 750 employees as well as a Regulatory and Corporate Engagement office in Brussels.
More information about Monsanto on http://discover.monsanto.com and http://monsanto.eu .
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150311006300/en/
Contact:
Press
Monsanto België
Frederik
Noak, 03/568.50.20
frederik.noak@monsanto.com
or
Whyte
Corporate Affairs
Mieke De Sutter, 02/738.06.20
mds@whyte.be
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum